Draft:MeMed Diagnostics

Troy Boutelle Joins MeMed as Vice President of Commercial in North America and General Manager, U.S.

Retrieved on: 
Tuesday, January 12, 2021
Boutell, Troy, New York, Troy, Michigan, Troy, Geography of the United States, States of the United States, Draft:MeMed Diagnostics

Troy Boutelle Joins MeMed as Vice President of Commercial in North America and General Manager, U.S.

Key Points: 
  • Troy Boutelle Joins MeMed as Vice President of Commercial in North America and General Manager, U.S.
  • Troy brings 20 years of top-flight sales and commercial experience as MeMed expands into the U.S. market
    HAIFA, Israel, January 12, 2021 MeMed, a leader in Advanced Host-Immune Response Technologies, today announces the appointment of Troy Boutelle as Vice President of Commercial, North America and General Manager, US.
  • Troy will spearhead MeMeds operations in North America from Boston, MA.
  • Troy has 20 years of experience in commercial leadership roles at life science companies in the US.

MeMed Appoints Industry Veteran Chris Hibberd to its Board of Directors

Retrieved on: 
Wednesday, December 16, 2020
Hibberd, Draft:MeMed Diagnostics

HAIFA, Israel, December 16, 2020 MeMed, a leader in host immune response-based solutions, today announced that Chris Hibberd has joined its Board of Directors.

Key Points: 
  • HAIFA, Israel, December 16, 2020 MeMed, a leader in host immune response-based solutions, today announced that Chris Hibberd has joined its Board of Directors.
  • Were delighted to welcome Chris Hibberd to our Board of Directors as we prepare for our next stage of growth, said Dr. Kfir Oved, MeMeds Co-founder, Chairman and CTO.
  • Chris brings deep domain expertise in building high medical value diagnostic franchises and will be a wonderful addition to our Board.
  • Chris joining our Board supports these efforts by further building the strategic leadership and operational excellence within it.

MeMed Selected to Present at BARDA Industry Day 2020

Retrieved on: 
Monday, October 26, 2020
DiaSorin, Biomedical Advanced Research and Development Authority, Haifa, Draft:MeMed Diagnostics

HAIFA, Israel,October 26,2020 MeMed, a leader in host immune response-based solutions, today announced that it has been selected to present a Lightning Talk at the BARDA Industry Day on Tuesday, October 27, 2020 at 3:40 to 4:40 pm EST.

Key Points: 
  • HAIFA, Israel,October 26,2020 MeMed, a leader in host immune response-based solutions, today announced that it has been selected to present a Lightning Talk at the BARDA Industry Day on Tuesday, October 27, 2020 at 3:40 to 4:40 pm EST.
  • Eden will also provide an update on MeMeds progress, including recent milestones such as its commercial partnership with DiaSorin and the CE Mark of MeMed Key and MeMed BV in Europe.
  • When combined, MeMed BV and MeMed Alert will facilitate quick and accurate triage decisions.
  • BARDA Industry Day is an annual meeting held to increase awareness of new developments across the healthcare industry that are designed to protect lives from public health threats.